ELISA Kit for Procollagen I N-Terminal Propeptide (PINP) Ver mas grande

ELISA Kit for Procollagen I N-Terminal Propeptide (PINP)

CC-CEA957Hu

Producto nuevo

48T, 96T, 96T×5, 96T×10, 96T×100

Más detalles

Por favor regístrese para ver el precio

Comprando este producto generará 6 Biopuntos. Su cesta contiene un total 6 Biopuntos puede ser convertido en un Biobonos Descuento 24.00EUR.


Añadir a Mis Favoritos

Hoja técnica

Size 96T
Storage Conditions -20°C
Shipping Conditions Entre 4°C y 8°C
Applications Enzyme-linked immunosorbent assay for Antigen Detection.
Detection Range 2.47-200ng/mL
Sensitivity The minimum detectable dose of this kit is typically less than 0.94ng/mL
Research Area Metabolic pathway
Organism species Homo sapiens (Human)
Alternative Names P1NP
Item Name Procollagen I N-Terminal Propeptide
Assay Length 2h
Method Competitive Inhibition
Sample Type serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
Formato 48T, <i>96T</i>, 96T×5, 96T×10, 96T×100
Test Principle This assay employs the competitive inhibition enzyme immunoassay technique. A monoclonal antibody specific to Procollagen I N-Terminal Propeptide (PINP) has been pre-coated onto a microplate. A competitive inhibition reaction is launched between biotin la
Assay procedure summary 1. Prepare all reagents, samples and standards
UniProt ID P02452

Más información

Click here for manual in PDF

Click here for OD Image


CITATIONS
Prognostic value of collagen turnover biomarkers in cardiac resynchronization therapy: A subanalysis of the TRUST CRT randomized trial population;Fibrosis of extracellular matrix is related to the duration of the disease but is unrelated to the dynamics of collagen metabolism in dilated cardiomyopathy;Bone turnover response is linked to both acute and established metabolic changes in ultra-marathon runners;The effect of calcium and vitamin D supplementation on bone health of male Jockeys.;Low periostin levels in adult patients with Langerhans cell histiocytosis are independently associated with the disease activity.;Erratum to: Effects on bone metabolism markers and arterial stiffness by switching to rivaroxaban from warfarin in patients with atrial fibrillation;A Study Protocol: Spinal Morphology, Physical Performance, Quality of Life and Biochemical Markers in Adults at Risk of Osteoporotic Fractures ;Periostin and sclerostin levels in juvenile Paget's disease;Congenital Hypothyroidism and Bone Remodeling Cycle;Relationship of biomarkers of extracellular matrix with myocardial function in Type 2 diabetes mellitus;12-month patterns of serum markers of collagen synthesis, transforming growth factor and connective tissue growth factor are similar in new-onset and chronic dilated cardiomyopathy in patients both with and without cardiac fibrosis.;Prognostic value of fibrosis-related markers in dilated cardiomyopathy: A link between osteopontin and cardiovascular events.;Specific Collagen Peptides Improve Bone Mineral Density and Bone Markers in Postmenopausal Women—A Randomized Controlled Study;Two-year cortical and trabecular bone loss in CKD-5D: biochemical and clinical predictors;Cholecalciferol Supplementation Promotes Bone Turnover in Chinese Adults with Vitamin D Deficiency;Geometric and mechanical bone response to a multidisciplinary weight loss intervention in adolescents with obesity: The ADIBOX study;Circulating matrix metalloproteinases and procollagen propeptides in inguinal hernia;Coupling of bone resorption and formation by RANKL reverse signalling;Structured diet and exercise guidance in pregnancy to improve health in women and their offspring: study protocol for the Be Healthy in Pregnancy (BHIP) …;Quantification of N-Terminal Procollagen I Propeptide in Patients With Occlusal Trauma Induced by Prosthetic Factors;Effect of antibiotic infused calcium sulfate/hydroxyapatite (CAS/HA) insets on implant-associated osteitis in a femur fracture model in mice;Low fibrosis biomarker levels predict cardiac resynchronization therapy response;Low concentration flufenamic acid enhances osteogenic differentiation of mesenchymal stem cells and suppresses bone loss by inhibition of the NF-κB …;Differences in Osteoimmunological Biomarkers Predictive of Psoriatic Arthritis among a Large Italian Cohort of Psoriatic Patients;Outcome in German and South African peripartum cardiomyopathy cohorts associates with medical therapy and fibrosis markers;Postmenapozal Tip-2 diyabetes mellitus' lu hastalarda osteoporoza bağlı kırık riskinin ve kemik Turnoveri'nin değerlendirilmesi;Low Energy Availability with and without a High-Protein Diet Suppresses Bone Formation and Increases Bone Resorption in Men: A Randomized Controlled Pilot ¡­;